
Australia's CSL tapped Amazon's cloud unit on Tuesday morning to harness artificial intelligence across its research and clinical development pipeline. The biotechnology firm announced the partnership to accelerate drug discovery timelines. The collaboration follows recent pricing agreements with the United States government.







